News Cigarette Smoking Doesn’t Speed Up Disease Progression in PPMS, Canadian Study Suggests Cigarette Smoking Doesn’t Speed Up Disease Progression in PPMS, Canadian Study Suggests by Patricia Inacio, PhD | June 20, 2017 Share this article: Share article via email Copy article link Cigarette smoking is certainly no good for you, but it may not necessarily make your primary progressive multiple sclerosis (PPMS) worse, a new study finds. The study, āSmoking does not influence disability accumulation in primary progressive multiple sclerosis,ā appeared inĀ the European JournalĀ ofĀ Neurology. It contradicts what was previously reported for relapsing-remitting MS (RRMS) patients ā suggesting thatĀ the underlying mechanisms driving these two manifestations of MS are different. Doctors have long known that smoking is aĀ risk factor for MS, with most studies focusingĀ on RRMS. āCigarette smokers have a higher risk of developing MS, an increased risk of conversion to clinically definite MS, an increased risk of reaching Expanded Disability Status Scale (EDSS) scores 4 and 6, and an increased number of demyelinating magnetic resonance imaging (MRI) lesions,ā the researchers wrote. Yet its long-term effect onĀ worsening disability in PPMS patients is still elusive. Researchers at Canada’s University of Calgary in Alberta have now investigated this possible link by retroactively analyzing dataĀ collected from the ongoingĀ Clinical Impact of Multiple SclerosisĀ study. From an initial pool of 4,862 patients with clinically definite MS, they identified 500 with PPMS, of which 416 (or 83 percent) had available smoking history. Outcomes included the time from disease onset to EDSS 4 and 6, and the time from EDSS 4 to 6. The analysis showed no significant association between cigarette smoking and disability accumulation in PPMS. The median time to EDSS 4 was four years for patients who had always smoked, and five years for never-smokers; for an EDSS of 6, the median time was nine years for both long-term and never-smokers. Additionally, PPMS patients who smoked showed no increased risk of reaching EDSS scores 4 and 6, nor ofĀ quickly progressing from EDSS 4 to 6. Rather, age at disease onset was found to be theĀ strongest risk factor for progression to EDSS 4 and 6, and from EDSS 4 to 6. āThis finding is in contrast to the influence of smoking on relapses, MRI lesions and disability accumulation in relapsing remitting disease which suggests that cigarette smoking may only contribute to inflammatory outcomes in relapse-onset MS,ā researchers wrote. Overall, theĀ team concluded that there isĀ āno association between cigarette smoking and disability accumulation and that age at disease onset remains the strongest prognostic factor for long-term outcomes in primary progressive MS. Our findings support the idea that disability accumulation in relapsing remitting MS and primary progressive MS depend on different underlying pathomechanisms, which are further differentially influenced by cigarette smoking.” Print This Page About the Author Patricia Inacio, PhD Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship. Tags disability, PPMS, progression, risk, RRMS, smoking
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Long-term data support early Kesimpta start in relapsing MS
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8